arrow
L

Lee Fairlie

University of the Witwatersrand
H指数:35
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Maternal 6-valent group B Streptococcus vaccine in non-pregnant and pregnant females: a randomized phase 1/2 trial

母体六价B族链球菌疫苗在非孕和孕产女性中的随机1/2期试验

2026-07-280
OAAI
Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study

在妊娠期间使用dapivirine阴道环或口服PrEP的婴儿的安全结局(MTN-042/DELIVER):一项随机3b期研究

2025-10-290
PRE
Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s

氯法齐明在利福平耐药结核病孕妇及产后妇女中的药代动力学与安全性:IMPAACT P1026s研究的结果

2025-10-010
PRE
Factors Predictive of Early Discontinuation of Preventive Treatment in Children With Household Exposure to Multidrug-resistant Tuberculosis

家庭暴露于耐多药结核病的儿童中,早期终止预防性治疗的相关预测因素

2025-07-180
OA
Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial

南非人类免疫缺陷病毒感染者中试验性结核病疫苗M72/AS01E–4的安全性及免疫原性:一项观察者盲法、随机对照、II期试验

2025-07-010
OAAI
Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s

左氧氟沙星治疗利福平耐药结核病在孕期及产褥期的药代动力学与安全性:IMPAACT P1026s研究的结果

2025-03-280
OA
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M™ adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial
2024-12-120
OAAI
Measles-Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations

麻疹-风疹微阵列贴片III期临床试验方案:提案与考量

2024-11-061
OAAI
Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants

基于Dolutegravir与基于Efavirenz的妊娠治疗: 对孕妇及其婴儿的红细胞叶酸浓度的影响

2024-06-150
PRE
Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial
AIDS
IF3.1
2024-03-011
OAAI
Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens
2024-01-2413
OAAI
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
2024-01-057
PRE
Preferences for onward health data use in the electronic age among maternity patients and providers in South Africa: a qualitative study

南非产科患者和提供者在电子时代对向前健康数据使用的偏好: 一项定性研究

2023-11-201
OAAI